ESC Premium Access

Treatment aims of glucose lowering drugs in patients with type 2 diabetes

Congress Presentation

About the speaker

Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)
37 presentations
1 follower

3 more presentations in this session

Liraglutide and empagliflozin – An evaluation of benefits.

Speaker: Associate Professor T. Schmidt (Copenhagen, DK)


Rethinking the appraisal and approval of drugs for type 2 diabetes.

Speaker: Professor A. Tsapas (Thessaloniki, GR)


Is type 2 diabetes a category error - How about treating the elderly?

Speaker: Professor G. Schernthaner (Vienna, AT)


Access the full session

Treatment of type 2 diabetes - Important new aspects for the cardiologist

Speakers: Professor L. Ryden, Associate Professor T. Schmidt, Professor A. Tsapas, Professor G. Schernthaner

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb